These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 395089)

  • 21. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
    Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
    J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The implantable infusion pump: a new concept in drug delivery.
    Blackshear PJ; Rohde TD; Prosl F; Buchwald H
    Med Prog Technol; 1979 Nov; 6(4):149-61. PubMed ID: 160505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensive insulin therapy: Part II. Multicomponent insulin regimens.
    Hirsch IB; Herter CD
    Am Fam Physician; 1992 Jun; 45(6):2643-8. PubMed ID: 1595513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Replacement treatment with insulin in diabetes mellitus: problems and promise.
    Dupre J; Champion MC; Rodger NW
    Clin Invest Med; 1982; 5(2-3):109-19. PubMed ID: 6749365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diabetes therapy with continuous insulin infusion by a portable pump: metabolic effects of short-term treatment and long-term results in problem patients].
    Schernthaner G; Graninger W; Kwasny W; Prager R; Otto C
    Acta Med Austriaca; 1982; 9(5-6):205-13. PubMed ID: 6762034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A portable insulin infusion system with a rotary solenoid-driven peristaltic pump.
    Carlson GA; Love JT; Urenda RS; Spencer WJ; Eaton RP
    Med Prog Technol; 1980; 8(1):49-56. PubMed ID: 7007857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
    Hildebrandt P
    Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.
    Lee SW; Cao M; Sajid S; Hayes M; Choi L; Rother C; de León R
    Diabetes Nutr Metab; 2004 Aug; 17(4):211-6. PubMed ID: 15575341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timing of insulin delivery with meals.
    Kraegen EW; Chisholm DJ; McNamara ME
    Horm Metab Res; 1981 Jul; 13(7):365-7. PubMed ID: 7024077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
    Kerner W; Beischer W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The use of artificial beta-cells or programmed insulin infusions in the therapy of insulin-dependent diabetes mellitus].
    Bruns W; Fischer U
    Z Gesamte Inn Med; 1981 Sep; 36(17):625-7. PubMed ID: 7048769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control.
    Radermecker RP; Renard E; Scheen AJ
    Diabetes Metab Res Rev; 2009 Sep; 25(6):491-501. PubMed ID: 19496088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of premeal subcutaneous insulin infusion and injection in type I diabetic patients under continuous basal subcutaneous insulin delivery.
    Navascués I; Kerner W; Pfeiffer EF
    Life Support Syst; 1985; 3(3):263-7. PubMed ID: 3900596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous blood glucose monitoring in insulin-treated diabetes.
    Mirouze J; Collard F; Selam JL; Pham J
    Horm Metab Res; 1977; Suppl 7():77-88. PubMed ID: 873445
    [No Abstract]   [Full Text] [Related]  

  • 35. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].
    Pfützner A; Berger S; Spinas G
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin pump therapy (continuous subcutaneous insulin infusion).
    White RD
    Prim Care; 2007 Dec; 34(4):845-71, vii. PubMed ID: 18061820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin infusion via a portable pump.
    Orzeck EA
    Tex Med; 1980 Jul; 76(7):46-9. PubMed ID: 6994269
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin infusion pumps in the treatment of diabetes.
    Blackshear PJ
    Med Instrum; 1982; 16(1):17-9. PubMed ID: 7038411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of dietary carbohydrates and proteins in the determination of postprandial insulin requirements, evaluated by artificial pancreas, in type I diabetics].
    Consoli A; Belletti F; Vitacolonna E; Capani F; Sensi S
    Boll Soc Ital Biol Sper; 1983 Apr; 59(4):499-501. PubMed ID: 6349660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.